Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Advanced Cell Technology, Inc. (ACTC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Advanced Cell Technology is a biotechnology company focused on the application of cellular technology in the field of regenerative medicine. The company specializes in developing cellular therapies to treat diseases and conditions impacting tens of millions of people across the globe. ACT is a leader in the field of regenerative medicine, developing stem cell-based technologies – both adult and human embryonic – and other proprietary methods for patient-specific therapies. For more information, visit the company’s Web site at www.advancedcell.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *